Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT
- PMID: 34069240
- PMCID: PMC8157146
- DOI: 10.3390/jcm10102131
Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT
Abstract
The prognosis for oligometastatic colorectal cancer has improved in recent years, mostly because of recent advances in new techniques and approaches to the treatment of oligometastases, including new surgical procedures, better systemic treatments, percutaneous ablation, and stereotactic body radiation therapy (SBRT). There are several factors to consider when deciding on the better approach for each patient: tumor factors (metachronous or synchronous metastases, RAS mutation, BRAF mutation, disease-free interval, size and number of metastases), patient factors (age, frailty, comorbidities, patient preferences), and physicians' factors (local expertise). These advances have presented major challenges and opportunities for oncologic multidisciplinary teams to treat patients with limited liver and lung metastases from colorectal cancer with a curative intention. In this review, we describe the different treatment options in patients with limited liver and lung metastases from colorectal cancer, and the possible combination of three approaches: systemic treatment, surgery, and local ablative treatments.
Keywords: ablation; colorectal cancer; liver metastases; lung metastases; oligometastasis; stereotactic body radiation therapy.
Conflict of interest statement
The authors declare no conflict of interest
Figures
Similar articles
-
Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer.Visc Med. 2017 Mar;33(1):54-61. doi: 10.1159/000454685. Epub 2017 Feb 3. Visc Med. 2017. PMID: 28612018 Free PMC article. Review.
-
A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.Semin Radiat Oncol. 2018 Oct;28(4):288-294. doi: 10.1016/j.semradonc.2018.06.009. Semin Radiat Oncol. 2018. PMID: 30309639 Review.
-
Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.Clin Colorectal Cancer. 2017 Mar;16(1):58-64. doi: 10.1016/j.clcc.2016.07.004. Epub 2016 Jul 18. Clin Colorectal Cancer. 2017. PMID: 27522627
-
Modern evidence and future prospects of external body radiation therapy for lung oligometastases of breast cancer.Transl Cancer Res. 2020 Aug;9(8):5077-5086. doi: 10.21037/tcr.2020.02.55. Transl Cancer Res. 2020. PMID: 35117873 Free PMC article. Review.
-
[Local ablative radiotherapy of oligometastatic colorectal cancer].Radiologe. 2017 Feb;57(2):105-110. doi: 10.1007/s00117-016-0201-z. Radiologe. 2017. PMID: 28054139 Review. German.
Cited by
-
Oligo-like liver metastasis: A novel prognostic indicator to improve survival in pancreatic cancer.Ann Gastroenterol Surg. 2023 Nov 13;8(3):481-489. doi: 10.1002/ags3.12753. eCollection 2024 May. Ann Gastroenterol Surg. 2023. PMID: 38707220 Free PMC article.
-
Optimizing Treatment Strategy for Oligometastases/Oligo-Recurrence of Colorectal Cancer.Cancers (Basel). 2023 Dec 27;16(1):142. doi: 10.3390/cancers16010142. Cancers (Basel). 2023. PMID: 38201569 Free PMC article. Review.
-
Stereotactic ablative brachytherapy versus percutaneous microwave ablation as salvage treatments for lung oligometastasis from colorectal cancer.BMC Cancer. 2024 Apr 16;24(1):481. doi: 10.1186/s12885-024-12163-3. BMC Cancer. 2024. PMID: 38627695 Free PMC article.
-
Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases.Ann Surg Oncol. 2023 Jul;30(7):4444-4454. doi: 10.1245/s10434-023-13279-9. Epub 2023 Mar 2. Ann Surg Oncol. 2023. PMID: 36864324
-
Predicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases.Clin Transl Radiat Oncol. 2022 Jul 21;36:91-98. doi: 10.1016/j.ctro.2022.07.006. eCollection 2022 Sep. Clin Transl Radiat Oncol. 2022. PMID: 35942398 Free PMC article.
References
-
- Van Cutsem E., Cervantes A., Adam R., Sobrero A., Van Krieken J.H., Aderka D., Aguilar E.A., Bardelli A., Benson A., Bodoky G., et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann. Oncol. 2016;27:1386–1422. doi: 10.1093/annonc/mdw235. - DOI - PubMed
-
- Andersen I.R., Thorup K., Jepsen B.N., Mortensen F.V., Nielsen D.T., Rasmussen F. Dynamic contrast-enhanced computed tomography in the treatment evaluation of patients with colorectal liver metastases treated with ablation: A feasibility study. Acta Radiol. 2019;60:936–945. doi: 10.1177/0284185118806661. - DOI - PubMed
-
- Ihara H., Gobara H., Hiraki T., Mitsuhashi T., Iguchi T., Fujiwara H., Matsui Y., Soh J., Toyooka S., Kanazawa S. Radiofrequency Ablation of Lung Tumors Using a Multitined Expandable Electrode: Impact of the Electrode Array Diameter on Local Tumor Progression. J. Vasc. Interv. Radiol. 2016;27:87–95. doi: 10.1016/j.jvir.2015.07.025. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials